Neumora Therapeutics (NMRA) Treasury Shares (2022 - 2026)

Neumora Therapeutics has reported Treasury Shares for 5 years, with the latest figure at $58000.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 94.76% year-over-year to $58000.0; the trailing twelve-month figure through Mar 2026 stood at $58000.0 (down 94.76% YoY), and the FY2025 full-year result was $662000.0, down 54.06% from the prior year.
• Treasury Shares for Q1 2026 stood at $58000.0, down from $662000.0 in the prior quarter.
• The five-year high for Treasury Shares was $2.9 million in Q4 2022, with the low at $58000.0 in Q1 2026.
• Average Treasury Shares over 5 years is $966750.0, with a median of $751000.0 recorded in 2023.
• Year-over-year, Treasury Shares soared 71.55% in 2024 and slumped 94.76% in 2026.
• Tracing NMRA's Treasury Shares over 5 years: stood at $2.9 million in 2022, then slumped by 71.05% to $840000.0 in 2023, then soared by 71.55% to $1.4 million in 2024, then plunged by 54.06% to $662000.0 in 2025, then tumbled by 91.24% to $58000.0 in 2026.
• The last three Treasury Shares figures came in at $58000.0 (Q1 2026), $662000.0 (Q4 2025), and $662000.0 (Q3 2025), per Business Quant data.

Peer Comparison